Navigation Links
China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9
Date:10/26/2010

SHANGHAI, Oct. 26 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced it will host a conference call at 8:00 a.m. Eastern Standard Time / 9:00 p.m. Beijing Time on Tuesday, November 9, 2010, to discuss the fiscal year 2011 second quarter and six months financial results for the period ended September 30, 2010.

The telephone numbers for the conference call are (866) 383-7998 (U.S.) or (617) 597-5329 (International), passcode: 45985589.  A live web cast of the call will also be available on the investor relations section of the Company's website www.chn-biotics.com. To listen to the web cast, please visit the site at least 10 minutes early to register, download and install any necessary audio software.

The replay of the web cast will be archived on the website, and investors will be able to access the recording of the conference call until midnight EST on November 16, 2010 by calling (888) 286-8010 (U.S.) or (617) 801-6888 (International) and entering passcode: 21680945.

About China-BioticsChina-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com.Contact:Travis Cai Chief Financial OfficerChina-Biotics, Inc.traviscai@chn-biotics.comShiwei Yin/Kevin Theiss Grayling646-284-9474shiwei.yin@grayling.comkevin.theiss@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics Hosted its First Investor Day Event
2. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
3. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
4. China-Biotics Provides Further Updates on Qingpu New Facility
5. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
6. China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11
7. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
8. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
9. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
10. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
11. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , Feb. 20, 2017 This report analyzes ... the following Product Types: Xylanase, Amylase, Cellulase, and Others. The ... Canada , Japan , ... Latin America , and Rest of World. ... Annual estimates and forecasts are provided for the period 2015 ...
(Date:2/20/2017)... ... February 20, 2017 , ... ... with catheters associated with peritoneal dialysis, announced today that it has published the ... connection system in Peritoneal Dialysis International (PDI), the official Journal of the ...
(Date:2/18/2017)... 18, 2017 Kurzlehrgang mit ... adoptiven Zelltherapie-Studien, Poster legt metaproteomische Analyse des Darm-Mikrobioms bei ... ... wird Dr. Yoav Peretz , Scientific Director bei ... von Assays zum Nachweis intrazellulärer Zytokine bei adoptiven Zelltherapie-Studien ...
(Date:2/17/2017)... 17, 2017  BioGenex, a global leader in ... a novel system for quantitative immunohistochemistry (IHC). The ... of Rochester (NY, USA) and Konica-Minolta Inc. ( ... is able to accurately quantify the expression of ... growth factor receptor-2) in clinical samples. Quantitative IHC ...
Breaking Biology Technology:
(Date:2/6/2017)... -- According to Acuity Market Intelligence, ongoing concerns ... continue to embrace biometric and digital identification based ... Control (ABC) eGates and 1436 Automated Passport Control ... ports of entry across the globe. Deployments increased ... CAGR of 37%. APC Kiosks reached 75% growth ...
(Date:2/2/2017)... -- EyeLock LLC, a market leader of iris-based identity authentication ... You Should Know About Biometrics in the Cloud ."  ... a growing concern. In traditional schemes, cryptography is used ... schemes such as username/password suffer from inherent weaknesses. ... elegant solution to the problem of high-security user authentication. ...
(Date:1/30/2017)... SAN FRANCISCO , Jan. 30, 2017   ... of the fastest growing genetic information companies, today announced ... 2016 financial results and provide 2017 guidance on Monday, ... a conference call that day at 4:45 p.m. Eastern ... call, Invitae,s management team will briefly review financial results, ...
Breaking Biology News(10 mins):